Valor pronóstico de la fracción alélica mutada (MAF) en el paciente con cáncer colorrectal

13 / 25

RESULTS
MAF 1st LINE 2nd LINE 3rd LINE
< 1% 6 (21%) 6 (50%) 1 (17%)
1-10% 9 (31%) 2 (17%) 1 (17%)
>10% 14 (48%) 4 (33%) 4 (66%)
Plasma MAF distribution